Introducing Trial Size Antibodies from BioVision: An Affordable Solution to Screen Multiple Targets!

MILPITAS, Calif. - April 13, 2016 - PRLog -- Trial size antibodies are convenient and economical solution for researchers to explore several targets for screening. BioVision is releasing hundreds of best performing Trail size antibodies to meet all your early stage research needs. Our affinity purified, thoroughly tested, highly specific antibodies will be affordable solution to test the antibody for your specific target.

Key Features:

· An affordable alternative for preliminary screening of multiple targets.

· Unique opportunity to evaluate the performance/specificity of antibody.

· Tested for various applications; WB, ELISA, IF, IHC, IP, Dot blot

· Optimal for optimization or small experiments.

·  Easily available from our stock.

·  Huge diversity, hundreds of targets for selection in various research areas.

BioVision's Trial size antibodies are available for following research areas:

1. Alzheimer's Research

2. Cell marker

3. Cell cycle and apoptosis

4. Immunology

5. Loading Control Antibodies

6. Metabolism and Epigenetic research

7. Neurobiology

8. Signaling Antibodies

9. Stem Cell

10. Tumor Biomarkers

11. And Many More

   Please click the link below to get more information:

http://www.biovision.com/antibodies-supporting-tools-467/...

Did not find your antibody in the above list then please contact tech@biovision.com for more information.